Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain

Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain Samphire Neuroscience has raised $5 million in seed funding to expand its Nettle brain device for menstrual symptoms, following strong market reception since its European launch earlier this year. The round was led by Nordic venture capital firm Inventure VC, with participation from US-based Fortify Ventures. Read More from the Global Wellness News…

Middle East Travel Spending to Hit 350 Billion USD by 2030 Amid Surge in Business, Luxury and Sports Tourism

Middle East Travel Spending to Hit 350 Billion USD by 2030 Amid Surge in Business, Luxury and Sports Tourism – Travel And Tour World Middle East travel spend will grow 50% by 2030 to $350B, driven by luxury, business, and sports tourism, according to ATM and Tourism Economics report. Read More from the Global Wellness News ™

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of weight-loss drugs called amylins is drawing the drug industry’s attention and dollars. Read the article on Barrons > Read More from the Global Wellness News ™

Wellness hotels outperformed the market in 2024 finds RLA Global insight

Wellness hotels outperformed the market in 2024 finds RLA Global insight | spabusiness.com news Hotels incorporating significant wellness amenities experienced strong top-line recovery in 2024, generating more than twice the Total Revenue per Available Room (TRevPAR) compared to hotels with no wellness income, according to the latest Wellness Real Estate Report by RLA Global, produced in partnership with P&L benchmarking firm HotStats. Read More from…